Related Experiment Video
Updated: May 20, 2026
08:28
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Kavalactone metabolism in rat liver microsomes
Shuang Fu1, Anthony Rowe, Iqbal Ramzan
1Faculty of Pharmacy, University of Sydney, NSW 2006, Australia.
Phytotherapy Research : PTR
|July 19, 2012
Summary
Kavalactone metabolism in rats involves specific CYP450 enzymes, with significant gender differences observed. This research identifies key enzymes like CYP3A and CYP2C for kavalactone (KLT) breakdown.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- Kavalactones (KLTs) are bioactive compounds found in kava, but their metabolic pathways and kinetics are not fully understood.
- Cytochrome P450 (CYP450) enzymes are crucial for xenobiotic metabolism, including KLTs.
Purpose of the Study:
- To determine enzyme kinetic parameters for major kavalactones (kavain, methysticin, desmethoxyyangonin) using rat liver microsomes.
- To identify the primary CYP450 isoforms responsible for KLT metabolism.
- To investigate potential gender-specific differences in KLT metabolism.
Main Methods:
- Incubation of rat liver microsomes (RLM) with kavain (KA), methysticin (MTS), and desmethoxyyangonin (DMY).
- Enzyme kinetic analysis to determine metabolic parameters.
- Inhibition studies using specific CYP450 inhibitors (clotrimazole, cimetidine, nortriptyline) to identify involved isoforms.
Main Results:
- KLT metabolite formation followed first-order kinetics.
- Clotrimazole potently inhibited KA and MTS metabolism in both male and female RLM, suggesting CYP3A involvement.
- Desmethoxyyangonin metabolism showed differential inhibition by cimetidine and nortriptyline, indicating involvement of CYP2C isoforms, with gender-specific differences.
Conclusions:
- CYP3A1/3A23 (females) and CYP3A2 (males) are the primary enzymes for KA and MTS metabolism in rats.
- DMY metabolism involves CYP2C6 and CYP2C11 in males, and CYP2C12 in females, with potential CYP3A involvement in females.
- Significant gender differences exist in the CYP450-mediated metabolism of kavalactones.
More Related Videos
Related Concept Videos
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...